Adam A., Levrat-Verny M.A., Lopez H.W., Leuillet M., Demigne C., and Remesy C. Whole wheat and triticale flours with differing viscosities stimulate cecal fermentations and lower plasma and hepatic lipids in rats. J Nutr 131 6 (2001 Jun) 1770-1776
Adam A., Lopez H.W., Tressol J.C., Leuillet M., Demigne C., and Remesy C. Impact of whole wheat flour and its milling fractions on the cecal fermentations and the plasma and liver lipids in rats. J Agric Food Chem 50 22 (2002 Oct 23) 6557-6562
Delzenne N.M., and Cani P.D. A place for dietary fibre in the management of the metabolic syndrome. Curr Opin Clin Nutr Metab Care 8 6 (2005 Nov) 636-640
Slavin J.L. Dietary fiber and body weight. Nutrition 21 3 (2005 Mar) 411-418
Drucker D.J. Biological actions and therapeutic potential of the glucagon-like peptides. Gastroenterology 122 2 (2002 Feb) 531-544
Burcelin R., Cani P.D., and Knauf C. Glucagon-like peptide-1 and energy homeostasis. J Nutr 137 11 Suppl (2007 Nov) 2534S-2538S
Shoelson S.E., Lee J., and Goldfine A.B. Inflammation and insulin resistance. J Clin Invest 116 7 (2006 Jul) 1793-1801
Shoelson S.E., Herrero L., and Naaz A. Obesity, inflammation, and insulin resistance. Gastroenterology 132 6 (2007 May) 2169-2180
Galisteo M., Duarte J., and Zarzuelo A. Effects of dietary fibers on disturbances clustered in the metabolic syndrome. J Nutr Biochem 19 2 (2008 Feb) 71-84
Delzenne N.M., Cani P.D., and Neyrinck A.M. Modulation of glucagon-like peptide 1 and energy metabolism by inulin and oligofructose: experimental data. J Nutr 137 11 Suppl (2007 Nov) 2547S-2551S
Cani P.D., Dewever C., and Delzenne N.M. Inulin-type fructans modulate gastrointestinal peptides involved in appetite regulation (glucagon-like peptide-1 and ghrelin) in rats. Br J Nutr 92 3 (2004 Sep) 521-526
Cani P.D., Knauf C., Iglesias M.A., Drucker D.J., Delzenne N.M., and Burcelin R. Improvement of glucose tolerance and hepatic insulin sensitivity by oligofructose requires a functional glucagon-like Peptide 1 receptor. Diabetes 55 5 (2006 May) 1484-1490
Cani P.D., Joly E., Horsmans Y., and Delzenne N.M. Oligofructose promotes satiety in healthy human: a pilot study. Eur J Clin Nutr 60 5 (2006 May) 567-572
Daubioul C.A., Horsmans Y., Lambert P., Danse E., and Delzenne N.M. Effects of oligofructose on glucose and lipid metabolism in patients with nonalcoholic steatohepatitis: results of a pilot study. Eur J Clin Nutr 59 5 (2005 May) 723-726
Slavin J. Why whole grains are protective: biological mechanisms. Proc Nutr Soc 62 1 (2003 Feb) 129-134
Meier J.J., and Nauck M.A. Glucagon-like peptide 1(GLP-1) in biology and pathology. Diabetes Metab Res Rev 21 2 (2005 Mar) 91-117
Delzenne N.M., Daubioul C., Neyrinck A., Lasa M., and Taper H.S. Inulin and oligofructose modulate lipid metabolism in animals: review of biochemical events and future prospects. Br J Nutr 87 Suppl 2 (2002 May) S255-S259
Kok N.N., Taper H.S., and Delzenne N.M. Oligofructose modulates lipid metabolism alterations induced by a fat-rich diet in rats. J Appl Toxicol 18 1 (1998 Jan) 47-53
Delmee E., Cani P.D., Gual G., Knauf C., Burcelin R., Maton N., et al. Relation between colonic proglucagon expression and metabolic response to oligofructose in high fat diet-fed mice. Life Sci 79 10 (2006 Aug 1) 1007-1013
Delzenne N.M., Cani P.D., Daubioul C., and Neyrinck A.M. Impact of inulin and oligofructose on gastrointestinal peptides. Br J Nutr 93 Suppl 1 (2005 Apr) S157-S161
Pachikian B., Neyrinck A.M., De Backer F., Cani P.D., and Delzenne N.M. Nutritional interest of cereal products in view of their content in fructans: analytical and physiological approach. Ann Nutr Metab 51 S1 (2007) 156
Amrein T.M., Granicher P., Arrigoni E., and Amado R. In vitro digestibility and colonic fermentability of aleurone isolated from wheat bran. Lebensmittel-Wissenschaft Und-Technologie-Food Sci Technol 36 4 (2003) 451-460
Philippe S., Barron C., Robert P., Devaux M.F., Saulnier L., and Guillon F. Characterization using Raman microspectroscopy of arabinoxylans in the walls of different cell types during the development of wheat endosperm. J Agric Food Chem 54 14 (2006 Jul 12) 5113-5119
Robert P., Marquis M., Barron C., Guillon F., and Saulnier L. FT-IR investigation of cell wall polysaccharides from cereal grains. Arabinoxylan infrared assignment. J Agric Food Chem 53 18 (2005 Sep 7) 7014-7018
Lopez H.W., Levrat M.A., Guy C., Messager A., Demigne C., and Remesy C. Effects of soluble corn bran arabinoxylans on cecal digestion, lipid metabolism, and mineral balance (Ca, Mg) in rats. J Nutr Biochem 10 9 (1999 Sep) 500-509
Lu Z.X., Gibson P.R., Muir J.G., Fielding M., and O'Dea K. Arabinoxylan fiber from a by-product of wheat flour processing behaves physiologically like a soluble, fermentable fiber in the large bowel of rats. J Nutr 130 8 (2000 Aug) 1984-1990
Lu Z.X., Walker K.Z., Muir J.G., Mascara T., and O'Dea K. Arabinoxylan fiber, a byproduct of wheat flour processing, reduces the postprandial glucose response in normoglycemic subjects. Am J Clin Nutr 71 5 (2000 May) 1123-1128
Lu Z.X., Walker K.Z., Muir J.G., and O'Dea K. Arabinoxylan fibre improves metabolic control in people with Type II diabetes. Eur J Clin Nutr 58 4 (2004 Apr) 621-628
Garcia A.L., Otto B., Reich S.C., Weickert M.O., Steiniger J., Machowetz A., et al. Arabinoxylan consumption decreases postprandial serum glucose, serum insulin and plasma total ghrelin response in subjects with impaired glucose tolerance. Eur J Clin Nutr 20 (2006 Sep)
Garcia A.L., Steiniger J., Reich S.C., Weickert M.O., Harsch I., Machowetz A., et al. Arabinoxylan fibre consumption improved glucose metabolism, but did not affect serum adipokines in subjects with impaired glucose tolerance. Horm Metab Res 38 11 (2006 Nov) 761-766
Cani P.D., Amar J., Iglesias M.A., Poggi M., Knauf C., Bastelica D., et al. Metabolic endotoxemia initiates obesity and insulin resistance. Diabetes 24 (2007 Apr)
Folch J., Lees M., and Sloane Stanley G.H. A simple method for the isolation and purification of total lipides from animal tissues. J Biol Chem 226 1 (1957 May) 497-509
Bradford M.M. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal Biochem 72 (1976 May 7) 248-254
Cani P.D., Neyrinck A.M., Fava F., Knauf C., Burcelin R.G., Tuohy K.M., et al. Selective increases of bifidobacteria in gut microflora improve high-fat-diet-induced diabetes in mice through a mechanism associated with endotoxaemia. Diabetologia 50 11 (2007 Nov) 2374-2383
Delzenne N., and Cani P.D. A place for dietary fibres in the management of metabolic syndrome. Curr Opin Clin Nutr Metab Care 8 6 (2005 Nov) 636-640
Backhed F., Manchester J.K., Semenkovich C.F., and Gordon J.I. Mechanisms underlying the resistance to diet-induced obesity in germ-free mice1. Proc Natl Acad Sci U S A 104 3 (2007 Jan 16) 979-984
Turnbaugh P.J., Ley R.E., Mahowald M.A., Magrini V., Mardis E.R., and Gordon J.I. An obesity-associated gut microbiome with increased capacity for energy harvest. Nature 444 7122 (2006 Dec 21) 1027-1031
Cani P.D., Bibiloni R., Knauf C., Waget A., Neyrinck A.M., Delzenne N.M., et al. Changes in gut microbiota control metabolic endotoxemia-induced inflammation in high-fat diet-induced obesity and diabetes in mice. Diabetes 57 6 (2008 Jun) 1470-1481
Kok N., Roberfroid M., Robert A., and Delzenne N. Involvement of lipogenesis in the lower VLDL secretion induced by oligofructose in rats. Br J Nutr 76 6 (1996 Dec) 881-890
Delzenne N.M. Oligosaccharides: state of the art. Proc Nutr Soc 62 1 (2003 Feb) 177-182
Demigne C., Remesy C., and Morand C. Short chain fatty acids. In: Gibson G., and Roberfroid M. (Eds). Colonic microbiota, nutrition and health (1999), Kluwer Academic Publisher, The Netherlands 55-63
Tappenden K.A., Drozdowski L.A., Thomson A.B., and McBurney M.I. Short-chain fatty acid-supplemented total parenteral nutrition alters intestinal structure, glucose transporter 2 (GLUT2) mRNA and protein, and proglucagon mRNA abundance in normal rats. Am J Clin Nutr 68 1 (1998 Jul) 118-125
Massimino S.P., McBurney M.I., Field C.J., Thomson A.B., Keelan M., Hayek M.G., et al. Fermentable dietary fiber increases GLP-1 secretion and improves glucose homeostasis despite increased intestinal glucose transport capacity in healthy dogs. J Nutr 128 10 (1998 Oct) 1786-1793
Reimer R.A., and McBurney M.I. Dietary fiber modulates intestinal proglucagon messenger ribonucleic acid and postprandial secretion of glucagon-like peptide-1 and insulin in rats. Endocrinology 137 9 (1996 Sep) 3948-3956
Meier J.J., Gallwitz B., Schmidt W.E., and Nauck M.A. Glucagon-like peptide 1 as a regulator of food intake and body weight: therapeutic perspectives. Eur J Pharmacol 440 2-3 (2002 Apr 12) 269-279
Zoran D.L., Turner N.D., Taddeo S.S., Chapkin R.S., and Lupton J.R. Wheat bran diet reduces tumor incidence in a rat model of colon cancer independent of effects on distal luminal butyrate concentrations. J Nutr 127 11 (1997 Nov) 2217-2225
Xu H., Barnes G.T., Yang Q., Tan G., Yang D., Chou C.J., et al. Chronic inflammation in fat plays a crucial role in the development of obesity-related insulin resistance. J Clin Invest 112 12 (2003 Dec) 1821-1830
Tataranni P.A., and Ortega E. A burning question: does an adipokine-induced activation of the immune system mediate the effect of overnutrition on type 2 diabetes?. Diabetes 54 4 (2005 Apr) 917-927
Neyrinck A.M., Mouson A., and Delzenne N.M. Dietary supplementation with laminarin, a fermentable marine beta (1-3) glucan, protects against hepatotoxicity induced by LPS in rat by modulating immune response in the hepatic tissue. Int Immunopharmacol 7 12 (2007 Dec 5) 1497-1506
Neyrinck A.M., Alexiou H., and Delzenne N.M. Kupffer cell activity is involved in the hepatoprotective effect of dietary oligofructose in rats with endotoxic shock. J Nutr 134 5 (2004 May) 1124-1129
Rose-John S., Waetzig G.H., Scheller J., Grotzinger J., and Seegert D. The IL-6/sIL-6R complex as a novel target for therapeutic approaches. Expert Opin Ther Targets 11 5 (2007 May) 613-624
Rose-John S., Scheller J., Elson G., and Jones S.A. Interleukin-6 biology is coordinated by membrane-bound and soluble receptors: role in inflammation and cancer. J Leukoc Biol 80 2 (2006 Aug) 227-236
Scheller J., Ohnesorge N., and Rose-John S. Interleukin-6 trans-signalling in chronic inflammation and cancer. Scand J Immunol 63 5 (2006 May) 321-329
Atreya R., and Neurath M.F. Involvement of IL-6 in the pathogenesis of inflammatory bowel disease and colon cancer. Clin Rev Allergy Immunol 28 3 (2005 Jun) 187-196
